A phase 1 trial of the bifunctional EGFR/TGFβ fusion protein BCA101 alone and in combination with pembrolizumab in patients with advanced solid tumors Meeting Abstract
| Authors: | Bedard, P. L.; Hernando-Calvo, A.; Carvajal, R. D.; Morris, V. K.; Paik, P. K.; Zandberg, D. P.; Kaczmar, J. M.; Niculescu, L.; Bohr, D.; Reiners, R.; Gharakhani, E.; Salazar, R.; Bilic, S.; Hanna, G. J. |
| Abstract Title: | A phase 1 trial of the bifunctional EGFR/TGFβ fusion protein BCA101 alone and in combination with pembrolizumab in patients with advanced solid tumors |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680300737 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.2513 |
| Notes: | Meeting Abstract: 2513 -- This meeting was also held virtually -- Source: Wos |
